- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07435896
Impact of Information and Participation on Decision Time for Tracheostomy or PEG in ICU Families
Impact of Information and Participation Strategies on Decision Time for Tracheostomy or PEG Among Family Members of Intensive Care Patients
Decisions regarding tracheostomy and percutaneous endoscopic gastrostomy (PEG) in the intensive care unit (ICU) are frequently associated with substantial uncertainty, decisional conflict, and psychosocial burden among patients' relatives. Inadequate or non-tailored information may negatively influence anxiety levels, decision satisfaction, and subsequent adaptation to care responsibilities. Differences in communication patterns and educational background may further affect how families perceive the risks, benefits, and long-term implications of these procedures.
This prospective study aims to evaluate the impact of relatives' educational level and different information delivery methods on anxiety, decision satisfaction, and the overall decision-making process related to tracheostomy and PEG in the ICU setting. The findings are expected to contribute to the development of structured, education-level-tailored information strategies to improve shared decision-making and family-centered care in critical care practice.
Study Overview
Status
Detailed Description
In the intensive care unit (ICU), decisions regarding tracheostomy and percutaneous endoscopic gastrostomy (PEG) create substantial uncertainty and psychosocial burden for patients' relatives. The literature reports that decisional conflict and regret are common in the tracheostomy decision-making process; one of the principal contributing factors is inadequate information provided to patients and their families. Furthermore, the lack of standardized and effective education regarding tracheostomy care negatively affects families' coping capacity and quality of life.
Differences in communication and perspectives between family members and the healthcare team significantly influence decision satisfaction and the alignment of expectations, underscoring the importance of structured information and counseling strategies. Evidence from tracheostomy care and education studies also indicates that increased knowledge levels are associated with improved caregiving skills and better psychosocial adaptation.
In addition, the literature suggests that tracheostomy decisions are perceived variably by families in terms of both benefits and potential adverse consequences, and that satisfaction levels differ according to individual expectations and the extent of information received. Therefore, it is necessary to systematically investigate the impact of relatives' educational level and different information delivery methods on the decision-making process.
This prospective study aims to evaluate the effects of relatives' educational level and information strategies on anxiety levels, satisfaction, and decision-making processes related to tracheostomy and PEG in the ICU setting.
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- First-degree relative of an ICU patient with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG)
- Age ≥ 18 years
- Able to understand and communicate in Turkish
- Provides written informed consent
- Responsible for or involved in the medical decision-making process
Exclusion Criteria:
- Cognitive impairment or psychiatric condition interfering with questionnaire completion
- Refusal to participate
- Prior participation in this study
- Inability to complete study questionnaires
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group E1
includes first-degree relatives of ICU patients indicated for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of primary school or below.
|
|
Group E2
includes first-degree relatives of ICU patients with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of secondary school or high school.
|
|
Group E3
includes first-degree relatives of ICU patients with an indication for tracheostomy and/or percutaneous endoscopic gastrostomy (PEG) who have a self-reported educational level of university degree or higher.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A) Score
Time Frame: Immediately before information delivery and immediately after completion of the information session (same day).
|
Anxiety levels of first-degree relatives will be assessed before and after the standardized information process using the Hospital Anxiety and Depression Scale (HADS), Turkish validated version. The HADS consists of 14 items, with the Anxiety subscale (HADS-A) comprising 7 items. The HADS-Anxiety subscale score ranges from 0 to 21, with higher scores indicating greater anxiety severity (worse outcome). The primary endpoint will be the change in HADS-Anxiety subscale score, calculated as post-information score minus pre-information score. |
Immediately before information delivery and immediately after completion of the information session (same day).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Total Score of the Family Satisfaction in the Intensive Care Unit Questionnaire (FS-ICU-24)
Time Frame: After completion of the decision-making process (within 24-48 hours following the information session).
|
Family satisfaction regarding care and decision-making will be evaluated using the Turkish validated version of the Family Satisfaction in the Intensive Care Unit questionnaire (FS-ICU-24). The FS-ICU-24 consists of 24 items assessing satisfaction with care and satisfaction with decision-making. Items are rated on a 5-point Likert scale and transformed to a 0-100 scale according to the standard scoring method, with higher scores indicating greater satisfaction (better outcome). Domain scores will be combined to calculate a single total score (0-100 scale). |
After completion of the decision-making process (within 24-48 hours following the information session).
|
|
Decision-Making Process Evaluation
Time Frame: Within 24-48 hours after the decision regarding tracheostomy and/or PEG.
|
Decision clarity, perceived participation in decision-making, and decisional conflict will be assessed using the decision-making domain of the Turkish validated version of the Family Satisfaction in the Intensive Care Unit questionnaire (FS-ICU-24). The FS-ICU-24 consists of 24 items rated on a 5-point Likert scale and transformed to a 0-100 scale according to the standard scoring method, with higher scores indicating greater satisfaction and better perceived decision-making quality. Mean domain scores will be calculated for each group and compared across educational levels and information methods. |
Within 24-48 hours after the decision regarding tracheostomy and/or PEG.
|
|
Demographic and Clinical Variables
Time Frame: At enrollment (baseline).
|
Patient and relative demographic and clinical data will be collected using a standardized data collection form for covariate analysis.
|
At enrollment (baseline).
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FSCH-SBÜ-2026/03 TPEG
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tracheostomy
-
University of MilanASST Santi Paolo e Carlo; Dejan Radovanovic; Marina Gatti; Michele Mondoni; Stefano... and other collaboratorsCompleted
-
Centre Hospitalier Universitaire, AmiensCompletedTracheostomy Hemorrhage | Tracheostomy Complications | Other Tracheostomy ComplicationsFrance
-
Universitatea de Medicina si Farmacie Iuliu HatieganuRecruitingTracheostomy Complication | Tracheostomy Infection | Tracheostomy HemorrhageRomania
-
Diskapi Yildirim Beyazit Education and Research...CompletedTracheostomy Complication | Percutaneous Tracheostomy | High-frequency Jet VentilationTurkey
-
Aksaray UniversityNot yet recruitingTracheostomy Complication | Percutaneous Tracheostomy | Airway Trauma | Tracheostomy HemorrhageTurkey
-
University of AlbertaAlberta Innovates Health SolutionsRecruiting
-
Katharina WinikerSwiss Paraplegic Research, NottwilRecruiting
-
Manchester University NHS Foundation TrustManchester Metropolitan UniversityCompleted
-
Johns Hopkins UniversityNot yet recruitingTracheostomyUnited States